1、 Price trend

According to the data of the business community, the average factory price of domestic caprolactam liquid on November 1 was 12500 yuan/ton, and on November 30, the average factory price of domestic caprolactam liquid was 12200 yuan/ton, down 2.10% this month.

2、 Market analysis

This month, the domestic caprolactam market trend is mainly downward. The price of raw material pure benzene fell, the cost support weakened, and the pure benzene market had a strong negative atmosphere. Most caprolactam manufacturers operate under reduced load, and the on-site supply is stable. Downstream demand is sluggish, and deals are light. The caprolactam market is weak under the negative factors. As of November 30, the price of Sinopec caprolactam liquid was 12800 yuan/ton.

This month, the raw material pure benzene market was hit by various negative effects, and the price fell due to shocks. Crude oil fell broadly and the cost was negative. The Asian American arbitrage window was closed, and the domestic price of pure benzene in China was at a high level, so the import volume of pure benzene in November was at a high level. Moreover, the overall supply of pure benzene market is sufficient. Downstream profitability is poor, styrene continues to decline, and the market is generally interested in buying pure benzene, which is a drag on the demand side. The price of Sinopec’s pure benzene fell by 950 yuan/ton to 6500 yuan/ton this month.

The domestic market of downstream PA6 fell this month. The load of domestic polymerization plants has decreased by a narrow margin, and the supply is still sufficient. On the demand side, the demand is relatively weak, and the rigid demand support is weakened. The contradiction between supply and demand has a certain drag on the market. Generally speaking, the market fundamentals are weak, and the market may continue to be weak.

3、 Future market forecast

Caprolactam analysts from the business community believe that the price of raw materials has fallen recently and the cost support of caprolactam is insufficient. On site supply is stable and downstream demand is weak. Led by negative factors, caprolactam market is expected to continue its weak operation in the short term.